Esperion Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Esperion Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Esperion Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Esperion Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $2.0M | 664k | 2.99 |
| 2023-09-30 | $743k | 758k | 0.98 |
| 2023-06-30 | $1.4M | 998k | 1.39 |
| 2023-03-31 | $1.8M | 1.1M | 1.59 |
| 2022-12-31 | $14M | 2.2M | 6.23 |
| 2022-06-30 | $1.9M | 298k | 6.35 |
| 2022-03-31 | $873k | 189k | 4.63 |
| 2021-12-31 | $2.4M | 471k | 5.00 |
| 2021-09-30 | $7.0M | 581k | 12.05 |
| 2021-06-30 | $10M | 473k | 21.14 |
| 2021-03-31 | $5.5M | 195k | 28.04 |
| 2020-12-31 | $9.8M | 376k | 26.00 |
| 2020-09-30 | $6.0M | 160k | 37.16 |
| 2020-06-30 | $10M | 203k | 51.31 |
| 2020-03-31 | $8.9M | 283k | 31.53 |
| 2019-12-31 | $18M | 305k | 59.63 |
| 2019-09-30 | $14M | 387k | 36.66 |
| 2019-06-30 | $15M | 323k | 44.78 |
| 2019-03-31 | $9.0M | 241k | 37.31 |
| 2018-12-31 | $8.5M | 186k | 46.00 |
| 2018-09-30 | $8.3M | 188k | 44.37 |
| 2018-06-30 | $6.8M | 173k | 39.19 |
| 2018-03-31 | $60M | 833k | 72.33 |
| 2017-12-31 | $33M | 493k | 65.84 |
| 2017-09-30 | $4.5M | 90k | 50.13 |
| 2017-06-30 | $2.2M | 47k | 46.28 |
| 2017-03-31 | $3.2M | 92k | 35.32 |
| 2016-12-31 | $125k | 10k | 12.50 |
| 2016-09-30 | $750k | 54k | 13.86 |
| 2016-06-30 | $177k | 18k | 9.86 |
| 2016-03-31 | $405k | 24k | 16.92 |
| 2015-12-31 | $155k | 6.9k | 22.31 |
| 2015-09-30 | $4.1M | 173k | 23.52 |
| 2015-03-31 | $11M | 113k | 92.60 |